Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that the Company has entered into a Memorandum of Understanding (“MoU”) with KARL STORZ VentureONE Pte. Ltd. (“KARL STORZ”), a wholly owned subsidiary of KARL STORZ SE & Co. KG, a global leader in the medical technologies industry, especially in the area of endoscopes, medical instruments, and devices that offers state-of-the-art technology for minimally invasive procedures in virtually all surgical specialties. As a solution-oriented and innovative partner, the independent family-owned company is in close collaboration with surgeons and health care partners around the globe to enable them to perform at their very best every day to improve patients' lives.
The definitive agreements to be developed under the MoU will include the following components:
o KARL STORZ intends to market and sell Asensus’ Intelligent Surgical Unit™ (ISU™) as a standalone device together with their IMAGE1 S™ Imaging system and OR1™ integration solution.
o The companies intend to work together on the integration of the ISU into KARL STORZ's laparoscopic vision systems
o The companies intend to jointly collaborate on developing next-generation instrumentation to be used with Asensus and KARL STORZ surgical platforms
The detailed terms are currently being negotiated, and definitive agreements will be finalized within 90 days.
https://finance.yahoo.com/news/asensus-karl-storz-market-intelligent-115500885.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.